The Impact of Regional Anesthetic Drugs on Fetal Development

The potential effects and teratogenic risks of using regional anesthetic drugs after vaginal tumor surgery on the fetus cannot be predicted. It is recommended to undergo a Down syndrome screening between 15 to 20 weeks of pregnancy to assess the fetus’s development, and symptomatic treatment should be administered if necessary.
One minute to read